Miglustat / OGT 918 in the Treatment of Cystic Fibrosis

Clinical trial NCT00537602 · TERMINATED

Trial details

NCT number: NCT00537602
Sponsor: Actelion
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Cystic Fibrosis

Start date: 2007-11-01
Primary completion: 2008-02-01
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.